A new solution for inline printing and 100% vision inspection of labels passed its Site Acceptance Test in June and is now ready for production. The system will reduce batch changeover time, reduce label waste and help pharmaceutical companies take more life-saving drugs to market.
With the new solution, pharmaceutical companies will need only one type of white label instead of hundreds of preprinted variants to accommodate all markets and product types.
The solution, developed by CIM, HAPA and PPS in a joint effort, is part of a small-batch pen assembly line delivered to a world-leading pharmaceutical company. It will support the company’s ambitions to reduce batch changeover time by automating as many processes as possible.
CIM’s part of the delivery is the software solution for digital print automation, which handles batch execution across all sub systems, integration to the main line, label inspection, GxP data logging and data collection for statistical process control.
“Our philosophy is to develop great standard products and combine them to create unique solutions and this is exactly what we have done here,” says CIM Site Director Anders Rohde, who has been leading the effort.
The SAT in June 2024 represents the culmination of years of hard work and Anders Rohde is very happy to finally see the solution making its way into production:
“While this specific project has been a year underway, we have been working on developing the technology for 4.5 years. It’s great to see that no-intervention inline label printing is indeed possible as this is crucial for reaching the level of flexibility in production needed for handling small batches efficiently.”
Read more about the solution here.